These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 23075747)

  • 1. A complementary care study combining flaxseed oil, caffeine, fasting, and exercise in women diagnosed with advanced ovarian cancer: findings from a case study.
    Albrecht TA; Anderson JG; Jones R; Bourguignon C; Taylor AG
    Holist Nurs Pract; 2012; 26(6):308-16. PubMed ID: 23075747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy.
    von Gruenigen VE; Frasure HE; Jenison EL; Hopkins MP; Gil KM
    Gynecol Oncol; 2006 Oct; 103(1):120-6. PubMed ID: 16556458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No stone left unturned: challenges encountered during recruitment of women with advanced ovarian cancer for a phase I study.
    Albrecht TA; Taylor AG
    Appl Nurs Res; 2013 Nov; 26(4):245-50. PubMed ID: 23871662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life.
    Beesley VL; Price MA; Butow PN; Green AC; Olsen CM; ; ; Webb PM
    Psychooncology; 2011 Nov; 20(11):1161-9. PubMed ID: 20740686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian women's perspectives on ovarian cancer.
    Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
    Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of psychological distress among women with ovarian cancer.
    Norton TR; Manne SL; Rubin S; Carlson J; Hernandez E; Edelson MI; Rosenblum N; Warshal D; Bergman C
    J Clin Oncol; 2004 Mar; 22(5):919-26. PubMed ID: 14990648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rising CA-125 levels in a patient with ovarian cancer are not always indicative of disease recurrence].
    Yerushalmi R; Rakowsky E; Sulkes A
    Harefuah; 2002 Apr; 141(4):347-8, 410. PubMed ID: 12017887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer.
    Oehler MK; Sütterlin M; Caffier H
    Anticancer Res; 1999; 19(4A):2513-8. PubMed ID: 10470185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological well being and quality of life in ovarian cancer survivors.
    Ferrell B; Smith SL; Cullinane CA; Melancon C
    Cancer; 2003 Sep; 98(5):1061-71. PubMed ID: 12942576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian cancer].
    Finnish Gynecological Association
    Duodecim; 2001; 117(22):2318-32. PubMed ID: 12183965
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-operative prediction of serum CA125 level in women with ovarian masses.
    Benjapibal M; Neungton C
    J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer.
    Kang S; Seo SS; Park SY
    J Surg Oncol; 2009 Sep; 100(3):244-7. PubMed ID: 19267361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy.
    von Gruenigen VE; Frasure HE; Kavanagh MB; Lerner E; Waggoner SE; Courneya KS
    Gynecol Oncol; 2011 Aug; 122(2):328-33. PubMed ID: 21600635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of anxiety and knowledge of serum CA-125 after an ovarian cancer diagnosis.
    Reid A; Ercolano E; Schwartz P; McCorkle R
    Clin J Oncol Nurs; 2011 Dec; 15(6):625-32. PubMed ID: 22119973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen.
    Bristow RE
    Gynecol Oncol; 2009 Jan; 112(1):1-3. PubMed ID: 19100914
    [No Abstract]   [Full Text] [Related]  

  • 17. The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.
    Parker PA; Kudelka A; Basen-Engquist K; Kavanagh J; de Moor J; Cohen L
    Gynecol Oncol; 2006 Mar; 100(3):495-500. PubMed ID: 16242759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.
    de Bruijn HW; van der Zee AG; Aalders JG
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):8-13. PubMed ID: 9090475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study.
    Low RN; Saleh F; Song SY; Shiftan TA; Barone RM; Lacey CG; Goldfarb PM
    Radiology; 1999 May; 211(2):519-28. PubMed ID: 10228537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.